Webinar: Treating Autosomal Recessive Deafness 9 with AAV1-hOTOF Gene Therapy (4/24/2024 10:00am EST/ 7:00am PST)

Abstract

Time

Speaker:

• 

  Name: Dr. Yilai Shu

  Institute/Company: Eye & ENT Hospital of Fudan University

  Title: Medical Doctor

  Dr. Yilai Shu, a preeminent figure in the field of otorhinolaryngology, embodies excellence in medical research and patient care. His role as Professor and Chief Physician at the Department of Otorhinolaryngology, Fudan University Affiliated Eye & ENT Hospital since December 2022 marks a significant milestone in a career that commenced with a foundational Bachelor of Clinical Medicine degree from Nanhua University. His academic journey is distinguished by an integrated Master’s and Ph.D. from Fudan University, and a joint Ph.D. program at Harvard Medical School and Massachusetts Eye and Ear Infirmary, reflecting his dedication to medical advancement and a fervent quest for knowledge.

  Dr. Shu’s scholarly contributions are remarkable, with over 86 SCI papers to his name, including more than 60 as first or corresponding author in globally renowned journals. His groundbreaking work in genetic deafness gene therapy, particularly through collaborative efforts with notable figures such as David Liu and Zheng-Yi Chen, has pioneered new therapeutic avenues. His research achievements have earned him prestigious recognitions, including the National Science Fund for Distinguished Young Scholars. Dr. Shu holds influential positions in key medical and scientific societies, driving forward the discourse in otorhinolaryngology on both national and international stages. His dedication to advancing healthcare through innovation and research underscores his profound impact on the medical community and patient care worldwide.

  Read more